Home
About Us
Company Profile
HIstory
Culture
Honor
Products
Cardiovascular series
Psychiatry series
Hepatobiliary, Gastroenterology Series
Respiratory series
Anti-infective virus series
Other series
Large Infusion Series
Huabao Tong Series
Active Pharmaceutical Ingredient Series
R&D
Academician Expert Workstation
Medical Research and Industry Alliance
News
General News
Party group dynamics
Employee activity
HR
Talent Strategy
Company recruitment
Contact us
中文版
2023/03/24
Public Notice for the 2,195-Ton Annual Production Project of Active Pharmaceutical Ingredients (Phase I) by Wanbangde Pharmaceutical Group Co., Ltd.
2023/02/27
Industry-Education Integration and School-Enterprise Collaboration | Wanbangde Pharmaceutical Group Successfully Selected for the "2021–2022 Zhejiang Province Industry-Education Integrated Enterprise" List!
2023/01/15
Honors | Wanbangde Pharmaceutical Group Named Among Top 500 High-Tech Enterprises in Zhejiang Province for Innovation Capability!
Good News! Wanbangde Pharmaceutical Group has been named to the "Most Promising Growth Enterprise in China's Pharmaceutical Industry" list for the fourth consecutive year!
2022/11/18
Public Notice on the Completion and Commissioning of Environmental Protection Facilities for the 980-Ton Per Year Norfloxacin Technology Upgrade Project (Front-End Supplement) at Wanbangde Pharmaceutical Group Co., Ltd.
2022/11/03
Quality Month | Wanbande Pharmaceutical Group’s 5th Annual QCC Selection Event Concludes Successfully
Create the present, shape the future | The Pharmaceutical Group's 5th "Quality Month" Event and Creative Quality Show Contest Conclude Successfully
Striving forward with determination and courage | Phase-wise summary of the Pharmaceutical Group's 6S management initiative released!
2022/10/15
Brand Powerhouse | The 2022 China Brand Value Evaluation Report Reveals: Wanbangde Pharmaceutical Group Named on the List of Independently Innovative Brands!
2022/10/12
Honors | Wanbangde Group Co., Ltd. Receives Zhejiang Province’s “Red Cross Benevolence Contribution Award”
Honors | Wanbangde Group Continues to Rank Among China's Top 500 Private Manufacturing Enterprises in 2022
Quality Month | Wanbangde Pharmaceutical Group Successfully Holds 2022 "Quality Month" Kickoff Event
2022/09/27
Focusing firmly on the goal, we’re determined to achieve it｜Wanbangde Pharmaceutical Group’s 6S Management “Two Weeks, One Benchmark” Expansion Zone – Phase 1: First-Phase Progress Review
2022/08/22
Stabilizing and Supporting Enterprises, Driving Steady Progress with Enhanced Quality | Taizhou Municipal Bureau's Fifth Service Team Visits Wanbangde
I participate, I improve, I persist, I succeed – the Wanbangde Pharmaceutical Group’s Lean 6S Management Project officially kicks off!
